Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in a Japanese population

被引:0
|
作者
Daimon, M
Oizumi, T
Saitoh, T
Kameda, W
Hirata, A
Yamaguchi, H
Ohnuma, H
Igarashi, M
Tominaga, M
Kato, T
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A327 / A327
页数:1
相关论文
共 50 条
  • [31] Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes
    Saraheimo, Markku
    Forsblom, Carol
    Thorn, Lena
    Waden, Johan
    Rosengard-Barlund, Milla
    Heikkilae, Outi
    Hietala, Kustaa
    Gordin, Daniel
    Frystyk, Jan
    Flyvbjerg, Allan
    Groop, Per-Henrik
    DIABETES CARE, 2008, 31 (06) : 1165 - 1169
  • [32] Serum Ethylamine Levels as an Indicator of l-Theanine Consumption and the Risk of Type 2 Diabetes in a General Japanese Population: The Hisayama Study
    Ninomiya, Toshiharu
    Kanzaki, Noriyuki
    Hirakawa, Yoichiro
    Yoshinari, Masahito
    Higashioka, Mayu
    Honda, Takanori
    Shibata, Mao
    Sakata, Satoko
    Yoshida, Daigo
    Teramoto, Takanori
    Takemoto, Susumu
    Nishimoto, Shozo
    Hata, Jun
    Kitazono, Takanari
    DIABETES CARE, 2019, 42 (07) : 1234 - 1240
  • [33] Genetic association of ADIPOQ gene variants with type 2 diabetes, obesity and serum adiponectin levels in south Indian population
    Ramya, Kandaswamy
    Ayyappa, Kuppuswamy Ashok
    Ghosh, Saurabh
    Mohan, Viswanathan
    Radha, Venkatesan
    GENE, 2013, 532 (02) : 253 - 262
  • [34] Linkage and association analyses of type 2 diabetes/impaired glucose metabolism and adiponectin serum levels in Japanese Americans from Hawaii
    Kovac, Ilija P.
    Havlik, Richard J.
    Foley, Daniel
    Peila, Rita
    Hernandez, Dena
    Wavrant-De Vrieze, Fabienne
    Singleton, Andrew
    Egan, Josephine
    Taub, Dennis
    Rodriguez, Beatriz
    Masaki, Kamal
    Curb, J. David
    Fujimoto, Wilfred Y.
    Wilson, Alexander F.
    DIABETES, 2007, 56 (02) : 537 - 540
  • [35] Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes
    Hirose, H
    Kawai, T
    Yamamoto, Y
    Taniyama, M
    Tomita, M
    Matsubara, K
    Okazaki, Y
    Ishii, T
    Oguma, Y
    Takei, I
    Saruta, T
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (03): : 314 - 317
  • [36] Decreased serum levels of adiponectin in subjects with autism
    Fujita-Shimizu, Azusa
    Suzuki, Katsuaki
    Nakamura, Kazuhiko
    Miyachi, Taishi
    Matsuzaki, Hideo
    Kajizuka, Masanobu
    Shinmura, Chie
    Iwata, Yasuhide
    Suda, Shiro
    Tsuchiya, Kenji J.
    Matsumoto, Kaori
    Sugihara, Genichi
    Iwata, Keiko
    Yamamoto, Shigeyuki
    Tsujii, Masatsugu
    Sugiyama, Toshiro
    Takei, Nori
    Mori, Norio
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (03): : 455 - 458
  • [37] Decreased serum adiponectin levels in children with NAFLD
    Louthan, M
    Sullivan, J
    McClain, C
    OBESITY RESEARCH, 2004, 12 : A124 - A124
  • [38] Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry
    Komorita, Yuji
    Iwase, Masanori
    Fujii, Hiroki
    Ohkuma, Toshiaki
    Ide, Hitoshi
    Jodai-Kitamura, Tamaki
    Sumi, Akiko
    Yoshinari, Masahito
    Nakamura, Udai
    Kang, Dongchon
    Kitazono, Takanari
    DIABETOLOGIA, 2017, 60 (10) : 1922 - 1930
  • [39] Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry
    Yuji Komorita
    Masanori Iwase
    Hiroki Fujii
    Toshiaki Ohkuma
    Hitoshi Ide
    Tamaki Jodai-Kitamura
    Akiko Sumi
    Masahito Yoshinari
    Udai Nakamura
    Dongchon Kang
    Takanari Kitazono
    Diabetologia, 2017, 60 : 1922 - 1930
  • [40] Acarbose treatment increases serum total adiponectin levels in patients with type 2 diabetes
    Ochiai, Hiromi
    Ooka, Hikari
    Shida, Chiho
    Ishikawa, Toshio
    Inoue, Daisuke
    Okazaki, Ryo
    ENDOCRINE JOURNAL, 2008, 55 (03) : 549 - 556